WAVE Life Sciences Ltd at Stifel CNS Days (Virtual) Transcript
Hey, good morning, everyone. I'm Alex Thompson. I'm the associate here. And Paul Matteis, [here] at Stifel. It's my pleasure to introduce Paul Bolno, CEO of Wave Life Therapeutics this morning. And maybe let's start off with Paul giving a brief intro, and then we'll go back and forth with a Q&A. And if anybody has any questions, feel free to submit them through the portal. But anyway, Paul, over to you.
Thanks, Alex. And we appreciate the time to update everybody on the continued progress at Wave. I mean, look, we're just -- we're focused now on what we've been since our foundation, which is on building a leading genetic medicines company, driving innovation in RNA therapeutics.
It's important to remember as well that our platform today really reflects now nearly a decade of investment in understanding new chemistries. And not just chirality, obviously that was -- our foundational principle is really understanding
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |